Drug Topics

JANUARY 17, 2025

Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.

Compounding 502

Compounding 502

Pharmacy Times

JANUARY 17, 2025

If finalized, the requirement would include readily available nutrition information, including saturated fat, sodium, and added sugar content.

Packaging 144

Packaging Labelling FDA 144

Drug Topics

JANUARY 17, 2025

A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.

Vaccines 466

Vaccines 466

Pharmacy Times

JANUARY 17, 2025

Acalabrutinib with bendamustine and rituximab shows efficacy in patients with untreated mantel cell lymphoma by increasing progression-free survival in the ECHO trial.

FDA 139

FDA 139

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JANUARY 17, 2025

Joseph DiPiro, PharmD, FCCP, FAAAS, editor of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast, discussed key themes in the forecast that will impact health-system pharmacy in 2025.

247

247

Pharmacy Times

JANUARY 17, 2025

These drugs are set to revolutionize their respective disease states in 2025.

137

137

Pharmacy Times

JANUARY 17, 2025

Admissions to the hospital for fever were reduced in pediatric patients with medium-risk ALL receiving intravenous immunoglobulin, a potentially useful finding to help prevent infections in vulnerable patients.

Hospitals 131

Hospitals 131

PharmaVoice

JANUARY 17, 2025

There’s more to pharma's regulatory story in 2025 than just the IRA.

Hospitals 130

Hospitals 130

Fierce Healthcare

JANUARY 17, 2025

Healthcare recoveries were once again the lion's share of fiscal year 2024's $2.9 billion total. Law enforcement highlighted big-ticket settlements with Rite Aid, Community Health Network and Oak Street Health, among others.

124

124

Pharmacy Times

JANUARY 17, 2025

The authors note that future research will observe personality changes when psilocybin is used in patients with opioid-use disorder.

121

121

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JANUARY 17, 2025

Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.

Hospitals 119

Hospitals 119

Pharmacy Times

JANUARY 17, 2025

Pharmacies are actively working to address issues and support their patients by collaborative with regulatory bodies like the Board of Pharmacy, and their engagement with the local community.

115

115

PQA

JANUARY 17, 2025

PQA has published anew reportdetailing technical recommendations for advancing health equity with PQA quality measures. Developed by the PQA Health Equity Technical Expert Panel (TEP), it provides key recommendations for PQA measure testing and use in quality programs. The TEP provided valuable health equity recommendations for PQA measure testing and use in quality programs, while also providing useful direction for future iterations of risk adjustment models.

Hospitals 52

Hospitals 52

Pharmacy Times

JANUARY 17, 2025

The report from the Office of Inspector General highlights inconsistencies, lack of transparency, and the need for stronger safeguards.

107

107

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmaceutical Technology

JANUARY 17, 2025

Shionogis S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao via Getty Images.

105

105

Fierce Healthcare

JANUARY 17, 2025

Only 61% of hospitals using AI or a predictive model report evaluating for accuracy using local data, and just 44% do so for bias, according to a recent study. Analyses suggest that hospitals with fewer resources are less likely to evaluate, leaving their patients at greater risk for harm.

Hospitals 104

Hospitals 104

pharmaphorum

JANUARY 17, 2025

Boehringer Ingelheim's bid to develop the first drug therapy for impaired cognitive function in schizophrenia looks like it has reached an end.

98

98

Pharmacy Times

JANUARY 17, 2025

Christopher Herndon, PharmD, BCACP, FASHP, FCCP, CPE, discusses the upcoming BPS pain management certification launching in late 2025, its role in validating pharmacist expertise.

94

94

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JANUARY 17, 2025

An AI can identify women who are at risk of experiencing a severe decline in cognitive function in menopause, which can be a risk factor for dementia.

80

80

Fierce Healthcare

JANUARY 17, 2025

The committee voted in favor of a draft recommendation to Congress that advocates for inpatient and outpatient increases as specified in current law plus an additional 1% in 2026. It also backed a $4 billion increase to a pool of funds for safety-net hospitals by adjusting how that money is distributed.

Hospitals 77

Hospitals 77

pharmaphorum

JANUARY 17, 2025

AstraZeneca's BTK inhibitor Calquence is the first drug in the class to be approved in the US for first-line treatment of mantle cell lymphoma.

75

75

Pharmacy Times

JANUARY 17, 2025

The FDA proposes to cap the nicotine level at 0.7 mg per gram of tobacco in cigarettes and certain other combusted tobacco products.

FDA 73

FDA 73

Pharmaceutical Commerce

JANUARY 17, 2025

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes compounding pharmacies efforts in tackling the tirzepatide shortage, and dispels the notion that commercialized and compounded drugs are competing with one another.

Compounding Pharmacies 64

Compounding Pharmacies Compounding 64

Pharmacy Times

JANUARY 17, 2025

Compared with chemotherapy, Dato-DXd demonstrates favorable median progression-free survival and overall survival in a phase 3 clinical trial.

Chemotherapy 72

Chemotherapy FDA 72

Pharmaceutical Technology

JANUARY 17, 2025

The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.

59

59

Pharmacy Times

JANUARY 17, 2025

Pharmacies are increasingly viewed as wellness hubs and community health partners.

65

65

Pharmaceutical Technology

JANUARY 17, 2025

IMPACT Therapeutics has received the China NMPA marketing authorisation for Senaparib capsules in treating ovarian cancer.

59

59

Pharmacy Times

JANUARY 17, 2025

Data from the CodeBreaK 300 trial supported the FDA's approval.

FDA 65

FDA 65

Pharmaceutical Commerce

JANUARY 17, 2025

The latest news for pharma industry insiders.

59

59

Pharmacy Times

JANUARY 17, 2025

Despite the reductions in hepatitis B surface antigen (HBsAg), grade 3 and 4 adverse events were not uncommon.

65

65

Pharmaceutical Technology

JANUARY 17, 2025

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZenecas position in the market.

59

59

pharmaphorum

JANUARY 17, 2025

Kardigan makes its debut with a teal of ex-MyoKardia execs and a $300m war chest, with a string of other biotechs also raising funds this week.

59

59

Pharmaceutical Technology

JANUARY 17, 2025

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in 2024.

FDA 59

FDA 59